Company profile
Vira Therapeutics company profile
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic (cancer-destroying) viruses. Our proprietary oncolytic virus, VSV-GP, efficiently destroys cancer cells, while leaving normal tissues unharmed. ViraTherapeutics currently performs preclinical safety and efficacy studies for VSV-GP and aims to conduct first clinical trials in cancer patients.
Business identity
- Contact email
- office(@)viratherapeutics.com
- Phone number
- +43512272061
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2015-06-24
Headquarters
- Headquarters
- Innsbruck, Tyrol, Austria
- Postal code
- 6020
- Country code
- AT
- Continent
- Europe